fbpx
February 20, 2023

Adjuvant Nivolumab as Standard of Care in Resected Bladder Cancer Adjuvant Nivolumab as Standard of Care in Resected Bladder Cancer

SAN FRANCISCO — New findings lend further support to adjuvant nivolumab (Opdivo) as a standard of care for patients with metastatic urothelial cancer. Extended follow-up data […]
February 20, 2023

New Diagnostic Imaging Agent Identifies Clear Cell Renal Cancer New Diagnostic Imaging Agent Identifies Clear Cell Renal Cancer

SAN FRANCISCO — A novel, noninvasive method was able to accurately and noninvasively identify clear cell renal carcinoma (ccRCC,), and shows promise for differentiating indeterminant renal […]
February 20, 2023

Endocrinologists Share Thoughts on Ethical Challenges Endocrinologists Share Thoughts on Ethical Challenges

Endocrinologists share their opinions on an array of ethical topics and sometimes gut-wrenching decisions encountered in clinical practice in a new Medscape Slideshow entitled, Right and Wrong […]
February 20, 2023

Maternal Infection in Pregnancy Ups Risk for Childhood Leukemia? Maternal Infection in Pregnancy Ups Risk for Childhood Leukemia?

Children born to mothers who had urinary or genital tract infections during pregnancy appear to have an increased risk for childhood leukemia, say researchers reporting a […]
February 20, 2023

FDA OKs Sparsentan for Rare Kidney Disease FDA OKs Sparsentan for Rare Kidney Disease

The US Food and Drug Administration (FDA) gave accelerated approval on February 17 to sparsentan (Filspari), the first non-immunosuppressive therapy labeled for treating adults with primary […]
February 18, 2023

Cardiology Group to Pay $2M to Settle False Claims Allegations Cardiology Group to Pay $2M to Settle False Claims Allegations

Florida Cardiology PA, and 10 cardiologists in the practice have agreed to pay the US government and the state of Florida $2 million to resolve allegations […]
February 17, 2023

FDA OKs First Drug for Geographic Atrophy, a Major Cause of Adult Blindness FDA OKs First Drug for Geographic Atrophy, a Major Cause of Adult Blindness

The US Food and Drug Administration (FDA) has approved pegcetacoplan injection (Syfovre) as the first treatment for geographic atrophy (GA), a major cause of adult blindness. […]
February 17, 2023

US Food Benefits to Poor to Shrink as Pandemic Provisions End US Food Benefits to Poor to Shrink as Pandemic Provisions End

(Reuters) – Low-income Americans will soon receive less in food assistance or completely lose their eligibility for the benefits, as the federal government ends policies adopted […]
February 17, 2023

Inside the Big Business of Clogged Arteries Inside the Big Business of Clogged Arteries

On June 14, 2017, just before noon, a doctor made an incision near a patient’s groin. Kari Kirk, a representative for the world’s largest medical device […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0